The results of qRT-PCR confirmed that the expression level of DUXAP8 was significantly reduced in the bone marrow tissues of AML patients compared with normal bone marrow (Figure 1B), which showed that DUXAP8 was involved in the development of AML. This evidence concerns the gene DUXAP8 and acute myeloid leukemia.